Search results
Order by most recent / most popular / relevance
Results: 1-4 of 4
Angiotensin receptor blocker not obvious under lead compound doctrine
- McDermott Will & Emery
- -
- USA
- -
- October 28 2010
The U.S. Court of Appeal for the Federal Circuit affirmed a district court’s holding that Mylan failed to establish a prima facie case of obviousness for Daiichi’s olmesartan medoxomil, which is the active ingredient in Benicar, an angiotensin receptor blocker (ARB) used to treat high blood pressure
On remand from Supreme Court, medical method of treatment claims found to be patentable subject matter
- McDermott Will & Emery
- -
- USA
- -
- January 31 2011
In a remand case from the U.S. Supreme Court to the U. S. Court of Appeals for the Federal Circuit, the Federal Circuit has now issued a post-Bilski decision finding that the claimed method of treatment claims are directed to patentable subject matter under 35 U.S.C. 101 because the recited steps satisfy the “machine-or-transformation test.”
Preliminary injunction for generic version of an anti-inflammatory suspension enjoined
- McDermott Will & Emery
- -
- USA
- -
- November 30 2010
The U.S. Court of Appeal for the Federal Circuit affirmed the grant of a preliminary injunction against the launch of a generic version of PULMICORT RESPULES inhalation suspension, an anti-inflammatory corticosteroid, concluding that AstraZeneca had shown a likelihood of success in its contention that the method claims, but not kit claims (which the district determined were invalid) infringe the patents-in-suit
In re brimonidine patent litigation: obviousness determinations revisited
- McDermott Will & Emery
- -
- USA
- -
- June 30 2011
The U.S. Court of Appeals for the Federal Circuit reversed-in-part and affirmed-in-part a district court finding of non-obviousness in a Hatch-Waxman litigation involving an improved brimonidine formulation for reducing intraocular pressure associated with glaucoma
Current Search
- Workarea - Litigation
- Workarea - Healthcare
- Firm Name - McDermott Will & Emery
- Author - Shilpa V. Patel